The FDA has granted diaDexus clearance to market an automated version of its PLAC test. The new product is used to determine a patient's risk of heart disease or stroke.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||